Overview
Jui-lien Chou is a Radiation Oncologist in Lubbock, Texas. Dr. Chou is rated as an Experienced provider by MediFind in the treatment of Intraductal Papilloma. Her top areas of expertise are Breast Cancer, Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, and Non-Small Cell Lung Cancer (NSCLC). Dr. Chou is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INDEMNITY
- POS
- PPO
Locations
Gabriel Axelrud is a Radiation Oncologist in Lubbock, Texas. Dr. Axelrud is rated as an Advanced provider by MediFind in the treatment of Intraductal Papilloma. His top areas of expertise are Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Pleuropulmonary Blastoma, and Breast Cancer. Dr. Axelrud is currently accepting new patients.
David Jenkins is a Radiation Oncologist in Lubbock, Texas. Dr. Jenkins is rated as a Distinguished provider by MediFind in the treatment of Intraductal Papilloma. His top areas of expertise are Breast Cancer in Men, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), and Breast Cancer. Dr. Jenkins is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung Cancer
- Breast CancerDr. Chou isExperienced. Learn about Breast Cancer.
- Cervical CancerDr. Chou isExperienced. Learn about Cervical Cancer.
- EGFR Positive Lung CancerDr. Chou isExperienced. Learn about EGFR Positive Lung Cancer.
- Intraductal PapillomaDr. Chou isExperienced. Learn about Intraductal Papilloma.
- Large-Cell Lung CarcinomaDr. Chou isExperienced. Learn about Large-Cell Lung Carcinoma.